NCT03069378 2025-10-29A Study of Talimogene Laherparepvec (T-VEC) in Combination With Pembrolizumab in Patients With Metastatic and/or Locally Advanced SarcomaMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting41 enrolled 8 charts